Progestogen (selective) — endometriosis
Dienogest
Brand names: Zalkya, Visanne
Adult dose
Dose: 2mg PO OD continuously
Route: Oral
Frequency: OD
Clinical pearls
- NICE NG73: medical management of endometriosis
- RCOG endometriosis guidance / ESHRE
- Highly selective progestogen with low androgenic activity; not licensed as standalone contraceptive
Contraindications
- Active VTE / arterial events
- Active or past sex steroid-dependent malignancy
- Undiagnosed vaginal bleeding
- Severe hepatic impairment
- Pregnancy
- Hypersensitivity
Side effects
- Menstrual irregularity (amenorrhoea common)
- Headache
- Mood change
- Acne
- Weight change
- Reduced bone mineral density (long-term)
- Liver dysfunction
Interactions
- Enzyme inducers (carbamazepine, rifampicin, St John's wort)
Monitoring
- Bleeding pattern
- BP
- Mood
- BMD if long-term
Reference: BNF; NICE NG73; RCOG endometriosis; ESHRE; https://bnf.nice.org.uk/drugs/dienogest/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21